Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 25.78
- Piotroski Score 7.00
- Grade N/A
- Symbol (UTMD)
- Company Utah Medical Products, Inc.
- Price $65.13
- Changes Percentage (-0.27%)
- Change -$0.18
- Day Low $65.08
- Day High $65.76
- Year High $87.99
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
- Last Earnings 08/02/2024
- Ex-Dividend for 5/16 Dividend 09/20/2024
- Dividend Payable 10/04/2024
- Today N/A
- Next Earnings (Estimated) 10/23/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $4.50
- Trailing P/E Ratio 14.98
- Forward P/E Ratio 14.98
- P/E Growth 14.98
- Net Income $16.64 M
Income Statement
Quarterly
Annual
Latest News of UTMD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Utah Medical Products, Inc. (UTMD) Stock Price, News, Quote & History
Utah Medical Products, Inc. specializes in developing, manufacturing, and distributing a wide range of medical devices for the global healthcare industry. They offer various products such as fetal mon...
By Yahoo! Finance | 2 months ago -
Capital Allocation Trends At Utah Medical Products (NASDAQ:UTMD) Aren't Ideal
To identify stocks with potential for long-term value multiplication, look for trends in growing Return on Capital Employed (ROCE) and increasing capital employed. Utah Medical Products (UTMD) shows a...
By Yahoo! Finance | 2 months ago -
Investors in Utah Medical Products (NASDAQ:UTMD) have unfortunately lost 27% over the last year
Investors in Utah Medical Products, Inc. have faced a 28% share price drop in the last year, underperforming the market. While EPS declined by 4.4%, it suggests some shareholders are concerned about t...
By Yahoo! Finance | 3 months ago
